508 related articles for article (PubMed ID: 29449267)
1. Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment.
Zhao Q; Eichten A; Parveen A; Adler C; Huang Y; Wang W; Ding Y; Adler A; Nevins T; Ni M; Wei Y; Thurston G
Cancer Res; 2018 May; 78(9):2370-2382. PubMed ID: 29449267
[TBL] [Abstract][Full Text] [Related]
2. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
[TBL] [Abstract][Full Text] [Related]
3. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
4. Hhip regulates tumor-stroma-mediated upregulation of tumor angiogenesis.
Agrawal V; Kim DY; Kwon YG
Exp Mol Med; 2017 Jan; 49(1):e289. PubMed ID: 28127049
[TBL] [Abstract][Full Text] [Related]
5. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
6. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
[TBL] [Abstract][Full Text] [Related]
7. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
[TBL] [Abstract][Full Text] [Related]
8. Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.
Miles KM; Seshadri M; Ciamporcero E; Adelaiye R; Gillard B; Sotomayor P; Attwood K; Shen L; Conroy D; Kuhnert F; Lalani AS; Thurston G; Pili R
PLoS One; 2014; 9(11):e112371. PubMed ID: 25393540
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
[TBL] [Abstract][Full Text] [Related]
10. Delta-like 4/Notch signaling promotes Apc
Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
[TBL] [Abstract][Full Text] [Related]
11. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
12. Delta-like ligand 4 regulates vascular endothelial growth factor receptor 2-driven luteal angiogenesis through induction of a tip/stalk phenotype in proliferating endothelial cells.
García-Pascual CM; Zimmermann RC; Ferrero H; Shawber CJ; Kitajewski J; Simón C; Pellicer A; Gómez R
Fertil Steril; 2013 Dec; 100(6):1768-76.e1. PubMed ID: 24074756
[TBL] [Abstract][Full Text] [Related]
13. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis.
Lee D; Kim D; Choi YB; Kang K; Sung ES; Ahn JH; Goo J; Yeom DH; Jang HS; Moon KD; Lee SH; You WK
MAbs; 2016 Jul; 8(5):892-904. PubMed ID: 27049350
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells.
Zhao XC; Dou GR; Wang L; Liang L; Tian DM; Cao XL; Qin HY; Wang CM; Zhang P; Han H
Neoplasia; 2013 Jul; 15(7):815-25. PubMed ID: 23814493
[TBL] [Abstract][Full Text] [Related]
16. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells.
Chen W; Tang T; Eastham-Anderson J; Dunlap D; Alicke B; Nannini M; Gould S; Yauch R; Modrusan Z; DuPree KJ; Darbonne WC; Plowman G; de Sauvage FJ; Callahan CA
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9589-94. PubMed ID: 21597001
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells.
Williams CK; Segarra M; Sierra Mde L; Sainson RC; Tosato G; Harris AL
Cancer Res; 2008 Mar; 68(6):1889-95. PubMed ID: 18339870
[TBL] [Abstract][Full Text] [Related]
18. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
19. Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
Hu W; Lu C; Dong HH; Huang J; Shen DY; Stone RL; Nick AM; Shahzad MM; Mora E; Jennings NB; Lee SJ; Roh JW; Matsuo K; Nishimura M; Goodman BW; Jaffe RB; Langley RR; Deavers MT; Lopez-Berestein G; Coleman RL; Sood AK
Cancer Res; 2011 Sep; 71(18):6030-9. PubMed ID: 21795478
[TBL] [Abstract][Full Text] [Related]
20. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
